BRUSSELS, Jan 18 The following are mergers under review by the European Commission and a brief guide to the EU merger process:
Jan 18 Eli Lilly and Co said it would buy CoLucid Pharmaceuticals Inc for about $960 million to gain access to its experimental treatment for migraine.
* Lilly and CoLucid Pharmaceuticals announce agreement for Lilly to acquire CoLucid
Jan 18 The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.
WASHINGTON, Jan 17 Danaher Corp co-founder Mitchell Rales agreed to pay $720,000 to settle allegations that he failed to report stock purchases to the government so that they could be vetted to determine if they violate antitrust law, antitrust enforcers said on Tuesday.
Jan 17 Wal-Mart Stores Inc and General Motors Co on Tuesday became the latest companies to win praise from President-elect Donald Trump for adding U.S. jobs and investment, even though much of their plans were previously announced.
WASHINGTON, Jan 17 A unit of Botox maker Allergan Plc will pay a $15 million penalty and admit to wrongdoing, after U.S. regulators on Tuesday accused the unit of failing to disclose 2014 merger talks with Actavis, the U.S. Securities and Exchange Commission said.
WASHINGTON, Jan 17 Botox maker Allergan plc will pay a $15 million penalty and admit to wrongdoing, after U.S. regulators on Tuesday accused the company of failing to disclose merger talks with Actavis, the U.S. Securities and Exchange Commission said.
* Trump elicited spending pledges from several big companies (Adds details on Bayer and Monsanto's previous R&D spending plans)
FRANKFURT, Jan 17 A future combined Bayer and Monsanto expects to spend about $16 billion on research and development over the next six years with at least half of this investment made in the United States, the two companies said in a statement on Tuesday.
WASHINGTON Donald Trump's pick for U.N. ambassador echoed his condemnation of the world body and pledged to push for reforms at her confirmation hearing on Wednesday, but broke from the president-elect on some other policy issues, including Russia and NATO. | Video